Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) saw unusually-high trading volume on Friday . Approximately 1,619,087 shares were traded during trading, an increase of 148% from the previous session’s volume of 653,662 shares.The stock last traded at $12.31 and had previously closed at $12.16.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on the company. Zacks Research downgraded Reckitt Benckiser Group from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 7th. Morgan Stanley raised Reckitt Benckiser Group from an “equal weight” rating to an “overweight” rating in a research note on Monday, March 16th. Finally, Kepler Capital Markets raised Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, April 17th. Two equities research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Reckitt Benckiser Group has a consensus rating of “Moderate Buy”.
Read Our Latest Stock Analysis on RBGLY
Reckitt Benckiser Group Stock Performance
About Reckitt Benckiser Group
Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.
The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
